Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
46, XY Disorders of Sex Development (D058490)
Parent Node:
expand
Genetic Diseases, Inborn (D030342)
Parent Node:
expand
Kidney Failure, Chronic (D007676)
..Starting node
..expand
Frasier Syndrome (D052159)

       Child Nodes:



 Sister Nodes: 
..expandFrasier Syndrome (D052159)
..expandNephropathy deafness hyperparathyroidism (C536401)
..expandNephropathy, Progressive, with Deafness (C563713)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:4410
Name:Frasier Syndrome
Definition:A syndrome characterized by CHRONIC KIDNEY FAILURE and GONADAL DYSGENESIS in phenotypic females with karyotype of 46,XY or female individual with a normal 46,XX karyotype. It is caused by donor splice-site mutations of Wilms tumor suppressor gene (GENES, WILMS TUMOR) on chromosome 11.
Alternative IDs:OMIM:136680
ParentIDs:MESH:D007676|MESH:D030342|MESH:D058490
TreeNumbers:C12.706.316.096.624 |C12.777.419.780.750.500.500 |C13.351.875.253.096.624 |C13.351.968.419.780.750.500.500 |C16.131.939.316.096.624 |C16.320.306 |C19.391.119.096.624
Synonyms:Syndrome, Frasier
Slim Mappings:Congenital abnormality|Endocrine system disease|Genetic disease (inborn)|Urogenital disease (female)|Urogenital disease (male)
Reference: MedGen: D052159
MeSH: D052159
OMIM: 136680;

Genes: WT1;
Phenotypes
1 HP:0000006Autosomal dominant inheritance
2 HP:0000097Focal segmental glomerulosclerosis
3 HP:0000133Gonadal dysgenesis
4 HP:0000037Male pseudohermaphroditism
5 HP:0000100Nephrotic syndrome
6 HP:0000149Ovarian gonadoblastoma
7 HP:0000786Primary amenorrhea
8 HP:0001428Somatic mutation
9 HP:0003774Stage 5 chronic kidney disease
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_001198551.1(WT1):c.787+15T>A7490WT1Pathogenic587776575RCV000003655; NMedGen:C0950122,OMIM:136680,ORPHA:347,SNOMED CT:445431000113241351232413512NM_001198551.1:c.787+15T>A11:g.32413512A>TOMIM Allelic Variant:607102.0019C0950122 136680 Frasier syndrome
NM_024426.4(WT1):c.1432+5G>A7490WT1Pathogenic587776576RCV000030876; RCV000003665; RCV000208283; NMedGen:C0950121,OMIM:194080,ORPHA:220,SNOMED CT:236385009; MedGen:C0950122,OMIM:136680,ORPHA:347,SNOMED CT:445431000; MedGen:CN043611113241351332413513NM_024426.4:c.1432+5G>AOMIM Allelic Variant:607102.0009,OMIM Allelic Variant:607102.0020C0950121 194080 Drash syndrome; C0950122 136680 Frasier syndrome; CN043611 Hereditary Nephrotic Syndromes
NM_024426.4(WT1):c.1432+4C>T7490WT1Pathogenic587776577RCV000003674; RCV000003675; RCV000157584; NMedGen:C0268747,OMIM:256370,SNOMED CT:111406002,SNOMED CT:236383002; MedGen:C0950122,OMIM:136680,ORPHA:347,SNOMED CT:445431000; MedGen:CN043611113241351432413514NM_024426.4:c.1432+4C>T11:g.32413514G>AOMIM Allelic Variant:607102.0018C0268747 256370 Diffuse mesangial sclerosis; C0950122 136680 Frasier syndrome; CN043611 Hereditary Nephrotic Syndromes
NM_024426.4(WT1):c.1378T>C (p.Phe460Leu)7490WT1Pathogenic28941779RCV000003679; NMedGen:C0950122,OMIM:136680,ORPHA:347,SNOMED CT:445431000113241357232413572NM_024426.4:c.1378T>CNP_077744.3:p.Phe460LeuNC_000011.9:g.32413572A>GOMIM Allelic Variant:607102.0025C0950122 136680 Frasier syndrome
NM_024426.4(WT1):c.1372C>T (p.Arg458Ter)7490WT1Pathogenic121907909RCV000003666; RCV000030877; NMedGen:C0950122,OMIM:136680,ORPHA:347,SNOMED CT:445431000; MedGen:CN033288,OMIM:194070113241357832413578NM_024426.4:c.1372C>TNP_077744.3:p.Arg458TerNC_000011.9:g.32413578G>AOMIM Allelic Variant:607102.0010,OMIM Allelic Variant:607102.0024C0950122 136680 Frasier syndrome; CN033288 194070 Wilms tumor 1